Rosen Law Firm Advocates for Gritstone bio, Inc. Investors Before Securities Class Action Deadline

New York, June 20, 2024 – In a significant announcement, Rosen Law Firm, internationally recognized for its dedication to investor rights, has issued a reminder to all who have acquired securities from GRTS Gritstone bio, Inc. during the period from March 9, 2023, to February 29, 2024. The firm stresses the urgency for these investors to consult legal advisors prior to the approaching August 6, 2024 deadline concerning the class action lawsuit against the company.

About Gritstone bio, Inc.

Gritstone bio, Inc., operating under the stock ticker GRTS, is a trailblazing biotechnology entity at the clinical stage, committed to the innovation of cancer immunotherapies that are precisely targeted to tumor-specific attributes. These advanced treatments are developed to battle a wide spectrum of cancers and infectious diseases. With its base of operations in Emeryville, California, Gritstone is at the forefront of pioneering health solutions.

Implications for Investors

Investors of Gritstone bio who fall within the confines of the specified class period are potentially affected by the current class action. The lawsuit aims to address concerns that the company may have issued materially misleading business information to the investing public. Those in possession of GRTS shares should be aware of their legal rights and the limited time frame within which they can act to participate in the class action and safeguard their interests.

investors, deadline, lawsuit